Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kajanti, M. J.
Right arrow Articles by Pyrhonen, S. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kajanti, M. J.
Right arrow Articles by Pyrhonen, S. O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 2:765-766, 1991
© 1991 European Society for Medical Oncology

other

Short report: Phase II trial of oral carmofur in advanced pancreatic carcinoma

M. J. Kajanti and S. O. Pyrhonen

Department of Radiotherapy and Oncology, Helsinki University Central Hospital Helsinki, Finland

Correspondence to: Mikael Kajanti, M.D. Department of Radiotherapy and Oncology, Helsinki University Central Hospital, Haartmaninkatu 4, SF-00290 Helsinki, Finland

Thirty-one patients with advanced carcinoma of the pancreas and with no prior exposure to chemotherapy were treated with HCFU. This drug was administered orally at a dose of 300–500 mg/m2 in 6-week cycles with a 2-week interval between the cycles. One partial response was observed and 7 patients showed stable disease. The median survival of the 31 patients was 8.3± 5.4 months (range 1.3–20.3 months). The toxicity was moderate.

pancreas carcinoma, oral carmofur


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.